Android Apple

Viridian Therapeutics, Inc. (VRDN) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$19.31

south_east -$0.36 (-1.83%)
Day's range
$18.77
Day's range
$19.44

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/12/2024 Stifel Nicolaus Alex Thompson $41.00 $11.41   259.33%
09/13/2024 RBC Capital Gregory Renza $44.00 $10.35   325.12%
09/11/2024 Needham Serge Belanger $38.00 $9.51   299.58%
09/11/2024 B.Riley Financial Kalpit Patel $22.00 $19.24   14.35%
09/10/2024 Stifel Nicolaus Alex Thompson $40.00 $8.68   360.83%
09/10/2024 BTIG Julian Harrison $56.00 $8.64   548.15%
08/14/2024 Goldman Sachs Richard Law $25.00 $14.18   76.3%
06/11/2024 RBC Capital Gregory Renza $35.00 $6.48   440.12%
06/11/2024 BTIG Julian Harrison $46.00 $6.48   609.88%
06/10/2024 Wolfe Research Andy Chen $29.00 $6.11   374.63%
06/06/2024 Goldman Sachs Richard Law $23.00 $6.17   272.77%
05/09/2024 Oppenheimer Leland Gershell $31.00 $7.45   316.11%
05/09/2024 H.C. Wainwright Douglas Tsao $27.00 $7.45   262.42%
05/08/2024 B.Riley Financial Kalpit Patel $20.00 $14.90   34.23%
No analyst forecast available for this stock.

Viridian Therapeutics, Inc. FAQ's

What analysts cover Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. has been rated by research analysts at Stifel Nicolaus, RBC Capital, Needham, B.Riley Financial, BTIG, Goldman Sachs in the past 90 days.

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.